Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement)

NCT01523418 · clinicaltrials.gov ↗

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Prophylaxis, Thromboembolism, Venous
Total Knee Replacement
Total Hip Replacement

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)

Sponsor

Bayer